The Insulin-like Growth Factor I Receptor/Insulin Receptor Tyrosine Kinase Inhibitor PQIP Exhibits Enhanced Antitumor Effects in Combination with Chemotherapy Against Colorectal Cancer Models

Kinase Inhibitor ◽

Antitumor Effects ◽

Factor I ◽

Cancer Models

Retracted: Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cellsin vitro

International Journal of Cancer ◽

10.1002/ijc.20917 ◽

2005 ◽

Vol 115 (4) ◽

pp. 630-640 ◽

Cited By ~ 24

Author(s):

Claudio Festuccia ◽

Giovanni Luca Gravina ◽

Adriano Angelucci ◽

Danilo Millimaggi ◽

Paola Muzi ◽

...

Keyword(s):

Prostate Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Antitumor Effects ◽

Expression of the pp63 gene encoding the insulin receptor tyrosine kinase inhibitor in proliferating liver and in liver tumors

Biochemical and Biophysical Research Communications ◽

10.1016/s0006-291x(05)81160-x ◽

1991 ◽

Vol 180 (2) ◽

pp. 967-971 ◽

Cited By ~ 3

Author(s):

Bruno M. Colombo ◽

Laurence Falquerho ◽

Giacomo Manenti ◽

Tommaso A. Dragani ◽

Alphonse Le Cam

Keyword(s):

Tyrosine Kinase ◽

Insulin Receptor ◽

Kinase Inhibitor ◽

Liver Tumors ◽

Gene Encoding ◽

Receptor Tyrosine Kinase Inhibitor

Phosphorylation of insulin-like growth factor I receptor by the insulin receptor tyrosine kinase in intact cultured skeletal muscle cells

Biochemistry ◽

10.1021/bi00409a015 ◽

1988 ◽

Vol 27 (9) ◽

pp. 3222-3228 ◽

Cited By ~ 27

Author(s):

Francesco Beguinot ◽

Robert J. Smith ◽

C. Ronald Kahn ◽

Ruth Maron ◽

Alan C. Moses ◽

...

Keyword(s):

Skeletal Muscle ◽

Growth Factor ◽

Tyrosine Kinase ◽

Insulin Receptor ◽

Muscle Cells ◽

Skeletal Muscle Cells ◽

Insulin Like Growth Factor ◽

Factor I

Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-09-0115 ◽

2009 ◽

Vol 8 (8) ◽

pp. 2122-2130 ◽

Cited By ~ 57

Author(s):

Zhenfeng Duan ◽

Edwin Choy ◽

David Harmon ◽

Cao Yang ◽

Keinosuke Ryu ◽

...

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Cell Lines ◽

Kinase Inhibitor ◽

Multidrug Resistant ◽

Osteosarcoma Cell ◽

Insulin Like Growth Factor ◽

Factor I

Efficacy of Cetuximab After Treatment with Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor—Based Chemotherapy in Metastatic Colorectal Cancer

Clinical Colorectal Cancer ◽

10.3816/ccc.2006.n.022 ◽

2006 ◽

Vol 6 (1) ◽

pp. 59-65 ◽

Cited By ~ 8

Author(s):

Jeffrey A. Meyerhardt ◽

Denise Heseltine ◽

Shuji Ogino ◽

Jeffrey W. Clark ◽

Peter C. Enzinger ◽

...

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Metastatic Colorectal Cancer ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Design of a selective insulin receptor tyrosine kinase inhibitor and its effect on glucose uptake and metabolism in intact cells

Biochemistry ◽

10.1021/bi00439a053 ◽

1989 ◽

Vol 28 (13) ◽

pp. 5694-5701 ◽

Cited By ~ 77

Author(s):

Richard Saperstein ◽

Pasquale P. Vicario ◽

H. Vincent Strout ◽

Edward Brady ◽

Eve E. Slater ◽

...

Keyword(s):

Tyrosine Kinase ◽

Insulin Receptor ◽

Glucose Uptake ◽

Kinase Inhibitor ◽

Intact Cells ◽

Receptor Tyrosine Kinase Inhibitor ◽

Uptake And Metabolism

Fruquintinib: a novel antivascular endothelial growth factor receptor tyrosine kinase inhibitor for the treatment of metastatic colorectal cancer

Cancer Management and Research ◽

10.2147/cmar.s215533 ◽

2019 ◽

Vol Volume 11 ◽

pp. 7787-7803 ◽

Cited By ~ 5

Author(s):

Ying Zhang ◽

Jia-Yun Zou ◽

Zhe Wang ◽

Ying Wang

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Tyrosine Kinase ◽

Metastatic Colorectal Cancer ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Antivascular Endothelial Growth Factor ◽

Endothelial Growth Factor

Differential expression of insulin receptor tyrosine kinase inhibitor (fetuin) gene in a model of diet-induced obesity

Life Sciences ◽

10.1016/s0024-3205(98)00250-1 ◽

1998 ◽

Vol 63 (2) ◽

pp. 145-153 ◽

Cited By ~ 50

Author(s):

X. Lin ◽

H.D. Braymer ◽

G.A. Bray ◽

D.A. York

Keyword(s):

Tyrosine Kinase ◽

Insulin Receptor ◽

Differential Expression ◽

Kinase Inhibitor ◽

Receptor Tyrosine Kinase Inhibitor ◽

Diet Induced Obesity

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

10.32388/jfobd7 ◽

2020 ◽

Author(s):

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Receptor Tyrosine Kinase Inhibitor ◽

Association between E-cadherin and sensitivity of hepatocellular carcinoma to treatment with epidermal growth factor receptor tyrosine kinase inhibitor

Academic Journal of Second Military Medical University ◽

10.3724/sp.j.1008.2014.00915 ◽

2014 ◽

Vol 35 (8) ◽

pp. 915

Author(s):

Rong-chun XING ◽

Jun ZHENG ◽

Ping CHEN ◽

Wei-hong ZHENG ◽

Wei LIU ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽